M. Goldston

发表

427 POSTER Pharmacokinetics (PK) of EZN-2208, a novel anticancer agent, in patients (pts) with advanced malignancies: a phase I dose-escalation study

A. Tolcher, C. Takimoto, T. Bekaii-Saab, 2008 .

Phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of AP23573, an mTOR Inhibitor, administered IV daily X 5 every other week in patients (pts) with refractory or advanced malignancies

A. Tolcher, M. Mita, C. Bedrosian, 2004 .

Pharmacokinetics (PK) and pharmacodynamics (PD) of E7820-an oral sulfonamide with novel, alpha-2 integrin mediated antiangiogenic properties: Results of a phase I study

A. Tolcher, C. Takimoto, M. Mita, 2005 .

Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.

A. Tolcher, T. Mays, A. Patnaik, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacodynamic study of skin biopsy specimens in patients (pts) with refractory or advanced malignancies following administration of AP23573, an mTOR inhibitor

A. Tolcher, J. Kreisberg, M. Mita, 2005 .

Phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of AP23573, an mTOR Inhibitor, administered IV daily X 5 every other week in patients (pts) with refractory or advanced malignancies.

A. Tolcher, M. Mita, C. Bedrosian, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Durable disease stabilization and antitumor activity with OSI-774 in renal cell carcinoma: A phase II, pharmacokinetic (PK) and biological correlative study with FDG-PET imaging.

A. Tolcher, G. Weiss, M. Beeram, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

409 AP23573, an mTOR inhibitor, administered IV daily × 5 every other week in patients with refractory or advanced malignancies — a phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study

A. Tolcher, M. Mita, C. Bedrosian, 2004 .